The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Book Review
PreviousPrevious
Volume 337:432-433 August 7, 1997 Number 6
NextNext

Oral Anticoagulants

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
Edited by Leon Poller and Jack Hirsh. 280 pp., illustrated. London, Arnold, 1996. (Distributed by Oxford University Press, New York.) $125. ISBN 0-340-55266-2.

Venous thromboembolism and arterial thromboembolism are leading causes of morbidity and mortality in the developed countries. During the past two decades, there has been substantial progress in understanding the mechanisms of thromboembolism, in clinical management, and in prophylaxis. Oral anticoagulants have been used for more than 50 years, but their role in treating and preventing thromboembolism has recently been greatly expanded. There are two reasons for this: excellent randomized clinical trials that have shown the efficacy of these drugs in, for example, reducing the risk of stroke in patients with atrial fibrillation, and the development of standardized methods to measure . . . [Full Text of this Article]




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.